AVITA Medical, Inc. (RCEL)

Compare

8.66

+0.12

+(1.41%)

As of 3:43:19 PM EST. Market Open.

AVITA Medical, Inc. (RCEL): A Bull Case Theory

We came across a bullish thesis on AVITA Medical, Inc. (NASDAQ:RCEL) on Substack by Steve Wagner. In this article, we will summarize the bulls’ thesis on RCEL. AVITA Medical, Inc. (NASDAQ:RCEL)’s share was trading at $8.94 as of Jan 8th. Avita Medical (NASDAQ:RCEL) has recently secured FDA approval for its new RECELL GO mini, a disposable cartridge […]

Insider Monkey 8 days ago

RCEL
+1.41%
AVITA Medical's shares sink 19% after another forecast cut

AVITA Medical's Australia-listed shares sank nearly 19% on Wednesday, set for their worst day in 15 months, after the regenerative medicine firm cut its forecast for the fourth time in five quarters and pushed out its profitability target. The U.S.-based company estimated its commercial revenue was about $64.3 million in fiscal 2024, lower than its forecast of $68 million to $70 million, due to slower-than-expected purchases from hospitals in the last quarter. AVITA's shares tumbled 18.8% to a two-month low of A$3.53, while the broader S&P/ASX 200 healthcare index was 0.7% higher.

Reuters 9 days ago

RCEL
+1.41%
AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance

VALENCIA, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced an update to its fourth quarter and full-year 2024 commercial revenue guidance. For the quarter ended December 31, 2024, AVITA Medical now expects commercial revenue to be approximately $18.4 million, reflecting growth of around 30% over the same period i

GlobeNewswire 9 days ago

AVHHL

RCEL
+1.41%
Exploring High Growth Tech Stocks in the United States December 2024

Over the last 7 days, the United States market has dropped 1.1%, yet it has risen by an impressive 22% over the past year, with earnings forecasted to grow by 15% annually. In this context of fluctuating short-term performance and promising long-term growth, identifying high growth tech stocks requires a focus on companies with strong innovation potential and robust financial health to capitalize on future opportunities.

Simply Wall St. 17 days ago

AVHHL

RCEL
+1.41%
PGY
Cantor Fitzgerald bullish on Avita Medical after FDA approval for RECELL GO Mini

Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat smaller wounds that aren’t addressed by RECELL GO. Importantly, the firm expects that approval for Mini will allow the company to target smaller wounds within the company’s full thickness skin defect indication. Cantor notes Avita plans to roll out Mini across trauma and burn centers that treat smaller wound

TipRanks 23 days ago

AVHHL

RCEL
+1.41%
Avita Medical initiated with a Buy at D. Boral Capital

D. Boral Capital initiated coverage of Avita Medical (RCEL) with a Buy rating and $25 price target Avita’s Recell technology has shown “promising results” in clinical trials for a variety of soft tissue and skin-related indications and Avita is “poised for significant growth” from expanding market penetration into trauma wounds, surgical wounds, and “slowly but surely chronic wounds” as awareness of the technology increases and adoption grows in hospitals and burn centers worldwide, the analyst

TipRanks 23 days ago

AVHHL

RCEL
+1.41%
FDA approves mini version of RECELL GO for smaller wounds

Avita’s RECELL platform uses the regenerative properties of the patient’s own skin for wound treatment.

Medical Device Network 24 days ago

RCEL
+1.41%
AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds

RECELL GO mini AVITA Medical receives FDA approval of RECELL GO mini, a new addition to the RECELL Spray-On Skin™ technology platform. VALENCIA, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the U.S. Food and Drug Administration (FDA) has approved its premarket approval (PMA) supplement for RECELL GO® min

GlobeNewswire 24 days ago

AVHHL

RCEL
+1.41%
AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market

New collagen-based dermal matrix designed for tissue generation, complementary to RECELL and PermeaDermCohealyx expected to triple AVITA Medical’s addressable market in burns VALENCIA, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance fo

GlobeNewswire 28 days ago

AVHHL

RCEL
+1.41%
AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

VALENCIA, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that Jim Corbett, Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025, at 9:00 a.m. Pacific Time. A live audio webcast of the presentation will be accessible under the Events & Presentat

GlobeNewswire 29 days ago

AVHHL

RCEL
+1.41%
Why Is AVITA Medical Inc. (RCEL) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?

We recently compiled a list of the 11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now. In this article, we are going to take a look at where AVITA Medical Inc. (NASDAQ:RCEL) stands against the other cosmetic surgery and aesthetics stocks. In the face of economic uncertainty, consumer preferences in the beauty industry are […]

Insider Monkey last month

RCEL
+1.41%
AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference

VALENCIA, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that Jim Corbett, Chief Executive Officer, will present at the at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024, at 11:30 a.m. Eastern Time. A live webcast of the fireside chat will be accessible under the Events & Prese

GlobeNewswire last month

AVHHL

RCEL
+1.41%
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand

VALENCIA, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a company specializing in commercial-stage regenerative medicine and pioneering devices for wound care management and skin restoration, today announced it has entered into an exclusive distribution agreement with Revolution Surgical Pty Ltd. This agreement marks an important milestone in our expansion into the Australian and New Zealand markets. Under the terms of the agreement, Revolution Surgical

GlobeNewswire 2 months ago

AVHHL

RCEL
+1.41%
AVITA Medical, Inc. (NASDAQ:RCEL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year

Shareholders of AVITA Medical, Inc. ( NASDAQ:RCEL ) will be pleased this week, given that the stock price is up 16% to...

Simply Wall St. 2 months ago

AVHHL

RCEL
+1.41%
AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Jim Corbett, Chief Executive Officer, and David O’Toole, Chief Financial Officer, on November 12, 2024, at 2:00 p.m. Pacific Standard Time (November 13, 2024, at 9:

GlobeNewswire 2 months ago

AVHHL

RCEL
+1.41%
AVITA Medical Reports Third Quarter Financial Results

VALENCIA, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today reported financial results for the third quarter ended September 30, 2024. Financial Results and Recent Business Updates Commercial revenue of $19.5 million, an increase of approximately 44% compared to the same period in 2023Gross profit margin of 83.7%On July 31,

GlobeNewswire 2 months ago

AVHHL

RCEL
+1.41%
AVITA Medical to Announce Third Quarter 2024 Financial Results

VALENCIA, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that it will report its third quarter 2024 financial results after the close of the U.S. financial markets on Thursday, November 7, 2024. AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Friday, November 8, 2024, a

GlobeNewswire 3 months ago

AVHHL

RCEL
+1.41%
AVITA Medical (NASDAQ:RCEL) shareholders have endured a 74% loss from investing in the stock five years ago

While not a mind-blowing move, it is good to see that the AVITA Medical, Inc. ( NASDAQ:RCEL ) share price has gained...

Simply Wall St. 3 months ago

AVHHL

RCEL
+1.41%
Top High Growth Tech Stocks To Watch In September 2024

The market is up 1.6% over the last week, with the Information Technology sector up 4.2%. In the last year, the market has climbed 22%, and earnings are forecast to grow by 15% annually. In this thriving environment, identifying high-growth tech stocks that align with these optimistic trends can be crucial for investors looking to capitalize on future opportunities.

Simply Wall St. 4 months ago

TBLA

TBLAW

AVHHL
AVITA Medical to Present at 2024 Cantor Global Healthcare Conference

VALENCIA, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that David O’Toole, Chief Financial Officer, will present at the 2024 Cantor Global Healthcare Conference on Wednesday, September 18, 2024, at 9:10 a.m. Eastern Time. A live webcast of the presentation will be accessible under the Events & Presentations

GlobeNewswire 4 months ago

AVHHL

RCEL
+1.41%

Performance Overview

Return	RCEL	S&P 500
YTD	-34.44%	+1.62%
1-Year	-39.36%	+25.95%
3-Year	-16.33%	+28.73%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

AVITA Medical, Inc. (RCEL)

AVITA Medical, Inc. (RCEL): A Bull Case Theory

AVITA Medical's shares sink 19% after another forecast cut

AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance

Exploring High Growth Tech Stocks in the United States December 2024

Cantor Fitzgerald bullish on Avita Medical after FDA approval for RECELL GO Mini

Avita Medical initiated with a Buy at D. Boral Capital

FDA approves mini version of RECELL GO for smaller wounds

AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds

AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market

AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Why Is AVITA Medical Inc. (RCEL) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?

AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference

AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand

AVITA Medical, Inc. (NASDAQ:RCEL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year

AVITA Medical to Host Investor Webinar Briefing

AVITA Medical Reports Third Quarter Financial Results

AVITA Medical to Announce Third Quarter 2024 Financial Results

AVITA Medical (NASDAQ:RCEL) shareholders have endured a 74% loss from investing in the stock five years ago

Top High Growth Tech Stocks To Watch In September 2024

AVITA Medical to Present at 2024 Cantor Global Healthcare Conference

Performance Overview